Skip to main content
. 2011 Oct 5;16(12):1684–1697. doi: 10.1634/theoncologist.2011-0113

Table 2.

Randomized phase III trials of bevacizumab in patients with breast cancer

graphic file with name onc01211-0921-t02.jpg

Abbreviations: AVADO, Avastin and Docetaxel; Cap, capecitabine; D, docetaxel; ECOG, Eastern Cooperative Oncology Group; FL MBC, first-line treatment for metastatic breast cancer; Gem, gemcitabine; HER-2, human epidermal growth factor receptor 2; Nab-Pac, nab-paclitaxel; P, paclitaxel; PFS, progression-free survival; PT MBC, previously treated metastatic breast cancer; RIBBOn, Regimens in Bevacizumab for Breast Oncology; VNR, vinorelbine.